medigraphic.com
Instituto Nacional de Salud Pública

2016, Number 6

<< Back Next >>

salud publica mex 2016; 58 (6)

The intellectual developmental disorders Mexico study: situational diagnosis, burden, genomics and intervention proposal

Lazcano-Ponce E, Katz G, Rodríguez-Valentín R, de Castro F, Allen-Leigh B, Márquez-Caraveo ME, Ramírez-García MÁ, Arroyo-García E, Medina-Mora ME, Ángeles G, Urquieta-Salomón JE,Salvador-Carulla L

Language: English
References: 93
Page: 694-707
PDF size: 623.89 Kb.


ABSTRACT

Objective. This study aims to generate evidence on intellectual development disorders (IDD) in Mexico. Materials and methods. IDD disease burden will be estimated with a probabilistic model, using population-based surveys. Direct and indirect costs of catastrophic expenses of families with a member with an IDD will be evaluated. Genomic characterization of IDD will include: sequencing participant exomes and performing bioinformatics analyses to identify de novo or inherited variants through trio analysis; identifying genetic variants associated with IDD, and validating randomly selected variants by polymerase chain reaction (PCR) and sequencing or real-time quantitative PCR (qPCR). Delphi surveys will be done on best practices for IDD diagnosis and management. An external evaluation will employ qualitative case studies of two social and labor inclusion programs for people with IDD. Conclusions. The results will constitute scientific evidence for the design, promotion and evaluation of public policies, which are currently absent on IDD.


REFERENCES

  1. Instituto Nacional de Estadística y Geografía (INEGI). Encuesta Nacional de la Dinámica Demográfica 2014 [internet document]. México: INEGI, 2014 [accessed: October 30, 2016]. Available in: http://www.inegi.org.mx/est/contenidos/proyectos/encuestas/hogares/ especiales/enadid/enadid2014/

  2. De Castro F, Allen-Leigh B, Katz G, Salvador-Carulla L, Lazcano-Ponce E. Indicadores de bienestar y desarrollo infantil en México. Salud Publica Mex 2013;55(supl 2):S267-S275.

  3. Lazcano-Ponce E, Katz G, Allen-Leigh B, Magaña Valladares L, Rangel-Eudave G, Minoletti A, et al. Trastornos del desarrollo intelectual en América Latina: un marco para establecer prioridades políticas de investigación y atención. Rev Panam Salud Publica 2013;34(3):204-209.

  4. Organización Mundial de la Salud. CIE 10: Trastornos mentales y del comportamiento. Descripciones clínicas y pautas para el diagnóstico. Clasificación Internacional de las Enfermedades Mentales. 10a Revisión. Madrid: Meditor, 1992.

  5. Salvador-Carulla L, Reed GM, Vaez-Azizi LM, Cooper SA, Martinez-Leal R, Bertelli M, et al. Intellectual developmental disorders: towards a new name, definition and framework for “mental retardation/intellectual disability” in ICD-11. World Psychiatry 2011;10(3):175-180. http://doi.org/btmv

  6. Kaufman L, Ayub M, Vincent JB. The genetic basis of non-syndromic intellectual disability: a review. J Neurodev Disord 2010;2(4):182-209. http:// doi.org/bvdm65

  7. United Nations. Convention on the rights of persons with disabilities [internet document]. UN Web Services Section, 2006 [accessed: September 30, 2016]. Available in: http://www.un.org/disabilities/convention/ convention.shtml

  8. Madans JH, Loeb ME, Altman BM. Measuring disability and monitoring the UN Convention on the Rights of Persons with Disabilities: the work of the Washington Group on Disability Statistics. BMC Public Health 2011;11(Suppl 4):S4.

  9. World Health Organization. World report on disability. Malta: WHO, 2011.

  10. Stephens T, Joubert N. The economic burden of mental health problems in Canada. Chronic Dis Can 2001;22(1):18-23.

  11. Doran CM, Einfeld SL, Madden RH, Otim M, Horstead SK, Ellis LA, Emerson E. How much does intellectual disability really cost? First estimates for Australia. J Intellect Dev Disabil 2012;37(1):42-49. http://doi.org/btmw

  12. Instituto Nacional de Estadística y Geografía (INEGI). Las personas con discapacidad en México: una visión al 2010. México: INEGI, 2010.

  13. Urquieta-Salomón JE, Figueroa JL, Hernández-Prado B. El gasto en salud relacionado con la condición de discapacidad: un análisis en población pobre de México. Salud Publica Mex 2008;50(2):136-146. http:// doi.org/bb38bv

  14. Curry CJ, Stevenson RE, Aughton D, Byrne J, Carey JC, Cassidy S, et al. Evaluation of mental retardation: recommendations of a Consensus Conference: American College of Medical Genetics. Am J Med Genet 1997;72(4):468-477. http://doi.org/bk3jxg

  15. Tzschach A, Ropers H. Genetics of Mental Retardation. Dtsch Arztebl 2007;104(20):A1400-A1405.

  16. American Psychiatric Association (APA). Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). Arlington, VA (USA): American Psychiatric Publishing, 2013.

  17. Fombonne E. Epidemiology of pervasive developmental disorders. Pediatr Res 2009;65(6):591-598. http://doi.org/fppgjn

  18. Kuntsi J, Eley TC, Taylor A, Hughes C, Asherson P, Caspi A, et al. Cooccurrence of ADHD and low IQ has genetic origins. Am J Med Genet B Neuropsychiatric Genet 2004;124B(1):41-47. http://doi.org/d5ctcg

  19. Simonoff E, Pickles A, Wood N, Gringras P, Chadwick O. ADHD symptoms in children with mild intellectual disability. J Am Acad Child Adolesc Psychiatry 2007;46(5):591-600. http://doi.org/b4fxhq

  20. Gadow KD, Devincent CJ, Pomeroy J, Azizian A. Comparison of DSM-IV symptoms in elementary school-age children with PDD versus clinic and community samples. Autism 2005;9(4):392-415. http://doi.org/ds27h9

  21. Gargaro BA, Rinehart NJ, Bradshaw JL, Tonge BJ, Sheppard DM. Autism and ADHD: how far have we come in the comorbidity debate? Neurosci Biobehav Rev 2011;35(5):1081-1088. http://doi.org/ckzdhb

  22. Kummer A, Barbosa IG, Rodrigues DH, Rocha NP, Rafael MD, Pfeilsticker L, et al. Frequency of overweight and obesity in children and adolescents with autism andattention deficit/hyperactivity disorder. Rev Paul Pediatr 2016;34(1):71-77. http://doi.org/btmx

  23. Krause S, Ware R, McPherson L, Lennox N, O’Callaghan M. Obesity in adolescents with intellectual disability: Prevalence and associated characteristics. Obes Res Clin Pract 2016;10(5):520-530. http://doi.org/btmz

  24. Biamino E, Di Gregorio E, Belligni EF, Keller R, Riberi E, Gandione M, et al. A novel 3q29 deletion associated with autism, intellectual disability, psychiatric disorders, and obesity. Am J Med Genet B Neuropsychiatr Genet 2016;171(2):290-299. http://doi.org/btm2

  25. Mundhofir FE, Winarni TI, van Bon BW, Aminah S, Nillesen WM, Merkx G, et al. A cytogenetic study in a large population of intellectually disabled Indonesians. Genet Test Mol Biomarkers 2012;16(5):412-417. http://doi. org/fxj4pn

  26. Reiss AL, Hall SS. Fragile X syndrome: assessment and treatment implications. Child Adolesc Psychiatr Clin N Am 2007;16(3):663-675. http:// doi.org/bgjjh4

  27. Rauch A, Wieczorek D, Graf E, Wieland T, Endele S, Schwarzmayr T, et al. Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study. Lancet 2012;380(9854):1674-1682. http://doi.org/f2fspm

  28. Sagoo GS, Butterworth AS, Sanderson S, Shaw-Smith C, Higgins JP, Burton H. Array CGH in patients with learning disability (mental retardation) and congenital anomalies: updated systematic review and meta-analysis of 19 studies and 13,926 subjects. Genet Med 2009;11(3):139-146. http://doi. org/bqsp6c

  29. Vissers LE, Gilissen C, Veltman JA. Genetic studies in intellectual disability and related disorders. Nat Rev Genet 2016;17(1):9-18. http://doi. org/btm3

  30. Srivastava AK, Schwartz CE. Intellectual disability and autism spectrum disorders: causal genes and molecular mechanisms. Neurosci Biobehav Rev 2014;46(Pt 2):161-174. http://doi.org/btm4

  31. Lionel AC, Crosbie J, Barbosa N, Goodale T, Thiruvahindrapuram B, Rickaby J, et al. Rare copy number variation discovery and crossdisorder comparisons identify risk genes for ADHD. Sci Transl Med 2011;3(95):95ra75. http://doi.org/bvtgqz

  32. Hiroi N, Takahashi T, Hishimoto A, Izumi T, Boku S, Hiramoto T. Copy number variation at 22q11.2: from rare variants to common mechanisms of developmental neuropsychiatric disorders. Mol Psychiatry 2013;18(11):1153-1165. http://doi.org/btm5

  33. Ramalingam A, Zhou XG, Fiedler SD, Brawner SJ, Joyce JM, Liu HY, et al. 16p13.11 Duplication is a risk factor for a wide spectrum of neuropsychiatric disorders. J Hum Genet 2011;56(7):541-544. http://doi.org/c98zd4

  34. van Bokhoven H. Genetic and epigenetic networks in intellectual disabilities. Annu Rev Genet 2011;45:81-104. http://doi.org/dqcggh

  35. Xu LM, Li JR, Huang Y, Zhao M, Tang X, Wei L. AutismKB: an evidence-based knowledgebase of autism genetics. Nucleic Acids Res 2012;40:D1016-D1022. http://doi.org/dc6bpk

  36. Delorme R, Ey E, Toro R, Leboyer M, Gillberg C, Bourgeron T. Progress toward treatments for synaptic defects in autism. Nat Med 2013;19(6):685-694. http://doi.org/f22vgn

  37. Gilman SR, Iossifov I, Levy D, Ronemus M, Wigler M, Vitkup D. Rare de novo variants associated with autism implicate a large functional network of genes involved in formation and function of synapses. Neuron 2011;70(5):898-907. http://doi.org/dz8msx

  38. Humeau Y, Gambino F, Chelly J, Vitale N. X-linked mental retardation: focus on synaptic function and plasticity. J Neurochem 2009;109(1):1-14. http://doi.org/cgjfqp

  39. Cristino AS, Williams SM, Hawi Z, An JY, Bellgrove MA, Schwartz CE, et al. Neurodevelopmental and neuropsychiatric disorders represent an interconnected molecular system. Mol Psychiatry 2014;19(3):294-301. http://doi.org/btm6

  40. Jiang YH, Wang Y, Xiu X, Choy KW, Pursley AN, Cheung SW. Genetic diagnosis of autism spectrum disorders: the opportunity and challenge in the genomics era. Crit Rev Clin Lab Sci 2014;51(5):249-262. http://doi. org/btm7

  41. Li Z, Chang SH, Zhang LY, Gao L, Wang J. Molecular genetic studies of ADHD and its candidate genes: a review. Psychiatry Res 2014;219(1):10- 24. http://doi.org/btm8

  42. Mefford HC, Batshaw ML, Hoffman EP. Genomics, intellectual disability, and autism. N Engl J Med 2012;366(8):733-743. http://doi.org/btm9

  43. Willemsen MH, Kleefstra T. Making headway with genetic diagnostics of intellectual disabilities. Clin Genet 2014;85(2):101-110. http://doi.org/btnb

  44. Miller DT, Adam MP, Aradhya S, Biesecker LG, Brothman AR, Carter NP, et al. Consensus statement: chromosomal microarray is a first tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet 2010;86(5):749-764. http://doi.org/ckmnsx

  45. de Ligt J, Willemsen MH, van Bon BW, Kleefstra T, Yntema HG, Kroes T, et al. Diagnostic exome sequencing in persons with sever intellectual disability. N Engl J Med 2012;367(20):1921-1929. http://doi.org/btnc

  46. Gilissen C, Hehir-Kwa JY, Thung DT, van de Vorst M, van Bon BW, Willemsen MH, et al. Genome sequencing identifies major causes of severe intellectual disability. Nature 2014;511(7509):344-347. http://doi.org/tdx

  47. World Health Organization. WHO methods and data sources for global burden of disease estimates 2000-2011. Geneve: WHO, 2013.

  48. Gregori D. Evidences to validate public policies: a review with an international research perspective. Salud Publica Mex 2014;56(Suppl 2):s157-s161.

  49. Instituto Nacional de Estadística y Geografía (INEGI). Sistema de Cuentas Nacionales. Cuenta Satélite del Trabajo no Remunerado de los Hogares. Fuentes y Metodología [internet document]. México: INEGI, 2013 [accessed: September 15, 2016]. Available in: http://www.inegi.org. mx/est/contenidos/proyectos/cn/tnrh/doc/SCNM_Metodologia_12.pdf

  50. Consejo Nacional de Evaluación de la Política de Desarrollo Social. Metodología para la medición multidimensional de la pobreza en México (2a ed.). México, DF: Coneval, 2014.

  51. Sheehan DV, Lecrubier Y, Shytle D, Milo K, Hergueta T, Colón SM. Mini International Neuropsychiatric Interview for children and adolescents [M.I.N.I. KID]. Version 1.1 Medical Outcome Systems, Inc. 2000.

  52. De la Peña OF, Esquivel AG, Pérez GAJ, Palacios CL. Validación Concurrente para Trastornos Externalizados del MINI-Kid y la Entrevista Semiestructurada para Adolescentes. Rev Chil Psiquiatr Neurol Infanc Adolesc 2009;20(1):8-12.

  53. Weschler D. Escala de inteligencia para escolares [Intelligence scale for schoolchildren]. WISC-IV. México: El Manual Moderno, 2005.

  54. Thorndike RL, Hagen EP, Sattler JM. Stanford-Binet intelligence scale. Chicago: Riverside Publishing Company. 1986.

  55. Sparrow SS, Balla DA, Cicchetti DV. Vineland-II adaptive behavior scales. Circle Pines, MN: American Guidance Service, 2005.

  56. Ustun TB, Kostanjsek N, Chatterji S, Rehm J. Measuring health and disability. Manual for WHO Disability Assessment Schedule, WHODAS 2.0. Geneva: WHO, 2010.

  57. Schopler E, Reichler RJ, Renner BR. The childhood autism rating scale (CARS). Los Angeles: Western Psychological Services, 1988.

  58. Flores RY, Albores GL. Validity of Mexican cars version. J Am Acad Child Adolesc Psychiatry 2016;55(10): S110.

  59. Rutter M, Le Couteur A, Lord C. Autism diagnostic interview-revised. Los Angeles: Western Psychological Services, 2003.

  60. Kumar A, Karmarkar AM, Tan A, Graham JE, Arcari CM, Ottenbacher KJ, et al. The effect of obesity on incidence of disability and mortality in Mexicans aged 50 years and older. Salud Publica Mex 2015;57(Suppl 1):S31-S38.

  61. Garrison E, Marth G. Haplotype-based variant detection from shortread sequencing. arXiv:1207.3907. Cornell University Library, 2012 [accessed October 30, 2016]. Available at: http//arvix.org/abs/1207.3907

  62. Barnes C, Plagnol V. CNVtools: A package to test genetic association with CNV data. R package version 1.64.0. 2009.

  63. Krumm N, Sudmant PH, Ko A, O’Roak BJ, Malig M, Coe BP, et al. Copy number variation detection and genotyping from exome sequence data. Genome Res 2012;22(8):1525-1532. http://doi.org/btnd

  64. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, et al. A method and server for predicting damaging missense mutations. Nat Methods 2010;7(4):248-249. http://doi.org/cc4rrw

  65. Kumar P, Henikoff S, Ng PC. Predicting the effects of coding nonsynonymous variants on protein function using the SIFT algorithm. Nat Protoc 2009;4(7):1073-1081. http://doi.org/bk5p4w

  66. Pawson R, Greenhalgh T, Harvey G, Walshe K. Realist review – a new method of systematic review designed for complex policy interventions. J Health Serv Res Policy 2005;10(1):21-34. http://doi.org/bq76wh

  67. Rycroft-Malone J, McCormack B, Hutchinson AM, DeCorby K, Bucknall TK, Kent B, et al. Realist synthesis: illustrating the method for implementation research. Implement Sci 2012;7(33):1-10. http://doi.org/f24k4f

  68. McVeigh J, MacLachlan M, Gilmore B, McClean C, Eide AH, Mannan H, et al. Promoting good policy for leadership and governance of health related rehabilitation: a realist synthesis. Global Health 2016;12(1):49. http://doi.org/btnf

  69. The Cochrane Collaboration. Cochrane Handbook for Systematic Reviews of Interventions [internet document]. London: The Cochrane Collaboration, 2015 [accessed November 8, 2016]. Available in: http:// handbook.cochrane.org/

  70. Kuipers P, Wirz S, Hartley S. Systematic synthesis of community-based rehabilitation (CBR) project evaluation reports for evidence-based policy: a proof-of-concept study. BMC Int Health Hum Rights 2008;8:3. http://doi. org/fgfcxj

  71. Kuipers P, Hartley S. A process for the systematic review of community- based rehabilitation evaluation reports: formulating evidence for policy and practice. Int J Rehabil Res 2006;29(1):27-30. http://doi.org/ccsbv6

  72. Petry K, Maes B, Vlaskamp C. Operationalizing quality of life for people with profound multiple disabilities: a Delphi study. J Intellect Disabil Res 2007;51(Pt 5):334-349. http://doi.org/c5cgbs

  73. Tuffrey-Wijne I, Bernal J, Butler G, Hollins S, Curfs L. Using Nominal Group Technique to investigate the views of people with intellectual disabilities on end-of-life care provision. J Adv Nurs 2007;58(1):80-89. http:// doi.org/fc45p8

  74. Dening KH, Jones L, Sampson EL. Preferences for end-of-life care: a nominal group study of people with dementia and their family carers. Palliat Med 2013;27(5):409-417. http://doi.org/btng

  75. Geist MR. Using the Delphi method to engage stakeholders: a comparison of two studies. Eval Program Plann 2010;33(2):147-154. http://doi. org/dqwwvz

  76. Linstone HA, Turoff M, eds. The Delphi Method. Techniques and Applications. Portland, New Jersey: Portland State University, New Jersey Institute of Technology, 2002.

  77. Okoli C, Pawlowski SD. The Delphi method as a research tool: an example, design considerations and applications. Information & Management 2004;42:15-29. http://doi.org/d7zrdc

  78. Yin RK. The Case Study Method as a Tool for Doing Evaluation. Current Sociology 1992;40:121-137. http://doi.org/b9s9jk

  79. Egan MY, Kubina LA, Lidstone RI, Macdougall GH, Raudoy AE. A critical reflection on occupational therapy within one Assertive Community Treatment team. Can J Occup Ther 2010;77(2):70-79. http://doi.org/fjrvs6

  80. Cornielje H, Nicholls PG, Velema J. Making sense of rehabilitation projects: classification by objectives. Lepr Rev 2000;71(4):472-485. http:// doi.org/btnh

  81. Cornielje H, Velema JP, Finkenflügel H. Community based rehabilitation programmes: monitoring and evaluation in order to measure results. Lepr Rev 2008;79(1):36-49.

  82. Velema JP, Finkenflügel HJ, Cornielje H. Gains and losses of structured information collection in the evaluation of ‘rehabilitation in the community’ programmes: ten lessons learnt during actual evaluations. Disabil Rehabil 2008;30(5):396-404. http://doi.org/fs43w4

  83. Velema JP, Cornielje H. Reflect before you act: providing structure to the evaluation of rehabilitation programmes. Disabil Rehabil 2003;25(22):1252-1264. http://doi.org/d8bs76

  84. Cornielje H, Nicholls PG, Velema JP. Avoiding misperceptions: classifying rehabilitation projects using letters rather than numbers. Lepr Rev 2002;73(1):47-51.

  85. Kuipers P, Foster M, Carlson G, Moy J. Classifying client goals in community-based ABI rehabilitation: a taxonomy for profiling service delivery and conceptualizing outcomes. Disabil Rehabil 2003;25(3):154- 162. http://doi.org/bdfq4m

  86. Doig E, Fleming J, Kuipers P, Cornwell PL. Comparison of rehabilitation outcomes in day hospital and home settings for people with acquired brain injury-a systematic review. Disabil Rehabil 2010;32(25):2061-2077. http://doi.org/c4k9nd

  87. Hsieh HF, Shannon SE. Three Approaches to Qualitative Content Analysis. Qual Health Res 2005;15(9):1277-1288. http://doi.org/bhp2s9

  88. Ryan GW, Bernard HR. Techniques to Identify Themes. Field Methods 2003;15:85-109. http://doi.org/b7bx2v

  89. Charmaz K. Constructing grounded theory: A practical guide through qualitative analysis. London: Sage, 2006.

  90. Ayres L, Kavanaugh K, Knafl KA. Within-case and across-case approaches to qualitative data analysis. Qual Health Res 2003;13(6):871-883. http://doi.org/cwvf4f

  91. Doig E, Fleming J, Cornwell PL, Kuipers P. Qualitative exploration of a client-centered, goal-directed approach to community-based occupational therapy for adults with traumatic brain injury. Am J Occup Ther 2009;63(5):559-568. http://doi.org/ctvrpr

  92. Kuipers P, Allen O. Preliminary guidelines for the implementation of Community Based Rehabilitation (CBR) approaches in rural, remote and Indigenous communities in Australia. Rural Remote Health 2004;4(3):291.

  93. Kuipers P, Kendall E, Hancock T. Developing a rural community-based disability service: (I) service framework and implementation strategy. Aust J Rural Health 2001;9(1):22-28. http://doi.org/bjcs9b




2020     |     www.medigraphic.com